Arabia Saudí -
inglés -
SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء
trelegy ellipta 100/62.5/25mcg inhalation powder, pre-dispensed inhalation powder, pre-dispensed
glaxo saudi arabia ltd., saudi arabia - fluticasone furoate,umeclidinium bromide,vilanterol - inhalation powder, pre-dispensed - 100,62.5,25 µg,
Japón -
inglés -
すりの適正使用協議会 RAD-AR Council, Japan
trelegy 100 ellipta 14 doses (テリルジー100エリプタ14吸入用)
glaxosmithkline k.k. - fluticasone furoate; umeclidinium bromide; vilanterol trifenatate - inhalation
Japón -
inglés -
すりの適正使用協議会 RAD-AR Council, Japan
trelegy 100 ellipta 30 doses (テリルジー100エリプタ30吸入用)
glaxosmithkline k.k. - fluticasone furoate; umeclidinium bromide; vilanterol trifenatate - inhalation
Japón -
inglés -
すりの適正使用協議会 RAD-AR Council, Japan
trelegy 200 ellipta 14 doses (テリルジー200エリプタ14吸入用)
glaxosmithkline k.k. - fluticasone furoate; umeclidinium bromide; vilanterol trifenatate - inhalation
Japón -
inglés -
すりの適正使用協議会 RAD-AR Council, Japan
trelegy 200 ellipta 30 doses (テリルジー200エリプタ30吸入用)
glaxosmithkline k.k. - fluticasone furoate; umeclidinium bromide; vilanterol trifenatate - inhalation
Singapur -
inglés -
HSA (Health Sciences Authority)
anoro ellipta inhalation powder 62.5 mcg25 mcg
glaxosmithkline pte ltd - (umec strip) umeclidinium bromide (micronised) 74.2 mcg/dose eqv umeclidinium; (vi strip) vilanterol trifenatate (micronised) 40 mcg/dose eqv vilanterol - powder, metered - (umec strip) umeclidinium bromide (micronised) 74.2 mcg/dose eqv umeclidinium 62.5 mcg/dose; (vi strip) vilanterol trifenatate (micronised) 40 mcg/dose eqv vilanterol 25 mcg/dose
Israel -
inglés -
Ministry of Health
spiolto respimat
boehringer ingelheim israel ltd. - olodaterol as hydrochloride; tiotropium bromide as monohydrate - solution for inhalation - olodaterol as hydrochloride 2.5 mcg; tiotropium bromide as monohydrate 2.5 mcg - vilanterol and umeclidinium bromide - spiolto respimat is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).
Canadá -
inglés -
Health Canada
incruse ellipta powder
glaxosmithkline inc - umeclidinium (umeclidinium bromide) - powder - 62.5mcg - umeclidinium (umeclidinium bromide) 62.5mcg - antimuscarinics antispasmodics
Australia -
inglés -
Department of Health (Therapeutic Goods Administration)
incruse ellipta umeclidinium (as bromide) 62.5 microgram powder for inhalation
glaxosmithkline australia pty ltd - umeclidinium bromide, quantity: 74.2 microgram (equivalent: umeclidinium, qty 62.5 microgram) - inhalation, powder for - excipient ingredients: magnesium stearate; lactose monohydrate - incruse ellipta is indicated as a long term once daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd)
Sudáfrica -
inglés -
South African Health Products Regulatory Authority (SAHPRA)
trelegy ellipta inhaler
glaxosmithkline south africa (pty) limited - inhaler - 92,0 μg/55,0 μg/22,0 μg - each delivered dose contains fluticasone furoate 92,0 μg; umeclidinium bromide equivalent to umeclidinium 55,0 μg; vilanterol trifenatate equivalent to vilanterol 22,0 μg